CompletedNCT00960713
The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Studying Autoimmune disease with skin involvement
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital, Toulouse
- Principal Investigator
- Laurent SaillerUniversity Hospital, Toulouse
- Intervention
- Rituximab (MABTHERA® or RITUXAN®).(drug)
- Enrollment
- 35 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2009 – 2012
Study locations (1)
- Service de médecine interne, hôpital Purpan, place du Dr Baylac, Toulouse, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00960713 on ClinicalTrials.gov